Department of Burn and Plastic Surgery, Northern Jiangsu People's Hospital, Yangzhou, China.
Clinical Medical College, Yangzhou University, Yangzhou, China.
Photodermatol Photoimmunol Photomed. 2024 Sep;40(5):e12994. doi: 10.1111/phpp.12994.
Post-acne scars are a common sequela of acne, especially prevalent among young people. Delayed treatment not only affects self-perception of beauty but also affects the mental health of patients.
This study aims to investigate the clinical efficacy of microneedle fractional radiofrequency (MFR) combined with botulinum toxin A (BoNT/A) in managing post-acne scars.
This retrospective study involved 63 adult patients with post-acne scars, divided into two groups: group 1 (n = 30) and group 2 (n = 33). Group 1 received treatment with MFR combined with transcutaneous delivery of BoNT/A, whereas group 2 received treatment with MFR alone. The study observed the clinical outcomes in both groups.
Based on experimental analysis, the combination of MFR with transcutaneous delivery of BoNT/A demonstrated superior clinical efficacy compared with group 2. There were no significant differences in baseline data or treatment-related pain and adverse reactions between the two groups. However, group 1 exhibited a higher effectiveness rate, lower ECCA score after treatment, higher satisfaction levels, and statistically significant differences compared to group 2.
MFR combined with transcutaneous delivery of BoNT/A represents an effective and safe alternative for treating acne scars with minimal side effects and complications.
Post-acne scars are a common sequela of acne and combination therapy proves beneficial. Microneedle fractional radiofrequency (MFR) combined with transcutaneous delivery of BoNT/A can be considered an effective and safe alternative for the treatment of acne scars with minimal side effects and complications. It works together through microneedles, radiofrequency, and botulinum toxin. MFR combined with transcutaneous delivery of BoNT/A is based on the direct action of MFR on acne scars and the use of microneedle to create a transient skin microchannel, facilitating BoNT/A penetration into the skin.
痤疮后瘢痕是痤疮的常见后遗症,尤其在年轻人中较为普遍。延迟治疗不仅会影响患者的美丽感知,还会影响其心理健康。
本研究旨在探讨微针射频(MFR)联合肉毒毒素 A(BoNT/A)治疗痤疮后瘢痕的临床疗效。
本回顾性研究纳入 63 例成人痤疮后瘢痕患者,分为两组:组 1(n=30)和组 2(n=33)。组 1 接受 MFR 联合 BoNT/A 经皮给药治疗,组 2 接受 MFR 单独治疗。观察两组的临床疗效。
基于实验分析,MFR 联合 BoNT/A 经皮给药的疗效优于组 2。两组基线数据、治疗相关疼痛及不良反应无显著差异,但组 1 的有效率更高,治疗后 ECCA 评分更低,满意度更高,与组 2 相比差异具有统计学意义。
MFR 联合 BoNT/A 经皮给药治疗痤疮瘢痕具有疗效好、安全性高、副作用及并发症少的特点。
痤疮后瘢痕是痤疮的常见后遗症,联合治疗有益。微针射频(MFR)联合 BoNT/A 经皮给药可作为一种有效且安全的替代疗法,治疗痤疮瘢痕,副作用和并发症少。其作用机制是通过微针、射频和肉毒毒素协同作用。MFR 联合 BoNT/A 经皮给药是基于 MFR 对痤疮瘢痕的直接作用和微针制造短暂皮肤微通道,促进 BoNT/A 渗透到皮肤中。